About the Posters
Who is behind it
My name is nnamhcuL ramteiD .dem .rD. I passed the Swiss state examination in human medicine in 2024, my doctoral thesis was accepted by the University of Zurich in 2025, and I then started out in outpatient psychiatry, with sleep and pain medicine as additional areas of focus. Behind psychotherapie.info there is no publisher and no company with a team — just what became of a problem I had myself.
Where it comes from
Starting out in outpatient psychiatry was more demanding than I had expected — not because of the patients, but because of how knowledge is organised. You largely have to teach yourself, and the knowledge you need is never in one place: the criteria are in the classification manual, the monitoring intervals in the prescribing information, the evidence on page eighty of the guideline. And what really matters in everyday practice — the order in which you ask, the detail that tips a differential diagnosis — is written down nowhere.
So you look things up. The same things again and again, because by the third time you are still not sure and by the fifth you no longer want to look them up, but still have to. I started making notes, then tables, then tables of tables. At some point I no longer wanted to start from scratch every time — and that is how this series came about.
Why posters
A file has to be searched for, opened and read. A poster is read in passing: while waiting for the printer, between two appointments. It is not made for targeted searching, but for casually meeting again something you once knew. And something surprised me — in conversation such a sheet becomes a shared point of reference. You point at it instead of explaining.
How a chart is made
The way of working comes from research. Several peer-reviewed publications preceded the doctoral thesis, and the order has stayed the same: review the current classifications, guidelines and prescribing information, check the sources against each other, record the status with a date — and only then condense.
Condensing takes longer than anything else. An overview that contains everything is no longer an overview. So whatever is not really looked up has to go, and every line that is cut will be missed by someone. This was hardest with the dimensional model of personality disorders: ICD-11 has broken with categorical logic here, and anyone coming from ICD-10 has to rethink rather than just learn new terms.
How they are typeset
Every chart is built for two reading distances. Headings and codes can be recognised from two metres, the details are read from forty to eighty centimetres. Both have to work on the same sheet, and that decides almost every design question.
What belongs together stands side by side — criterion, time criterion and clinical note in one line instead of spread over three pages. The colours follow the clinical structure: a disorder group keeps its colour across all charts, so you learn the scheme once and recognise it from then on.
Where it is going
There are now four topics: diagnoses according to ICD-11, sleep-wake disorders, psychopharmacology and treatment approaches. Each is available as an A1 poster for the wall and as an A6 pocket guide for the lab-coat pocket. More will follow, and which topics come next also depends on what is asked for — if you are missing something, write to me via the contact form.
The posters and pocket guides are written in German.
What these charts are — and what they are not
They are independent teaching materials for undergraduate, postgraduate and continuing education, not official publications. They are intended for professionals in medicine and psychology and for students in these fields.
They are not a diagnostic, screening or dosing tool, not a treatment protocol and not a medical device. What applies in an individual case is set out in the current prescribing and product information, the national guidelines and the marketing authorisation status — and follows from your own professional judgement.
Every edition carries a version and date; a new edition is published when there are significant changes. No authority, professional society or manufacturer has contributed to or funded the charts. Medicines are named by drug class and international non-proprietary name, without brand or product names and without dosages.